Print version of this report
TGA Action ID RC-2025-RN-00969-1
Type of Product Medical Device
Product Name/Description Anti-GBM. An in vitro diagnostic medical device (IVD).

Product Code: ORG 550

Batch Number: 2502555

UDI: 04260157080553

Expiry Date: 28.09.2026
ARTG Number 197247
Unique Device Identifier (UDI) 04260157080553
Action Type Product Correction
Action Level Hospital
Hazard Classification Class II
Reason for the Action A customer has reported a high number of non-plausible low positive results obtained with Anti-GBM (ORG 550) lot #2502555. The outcome of an internal evaluation by the manufacturer has showed a clinical specificity of 86.0% instead of 99.3% as claimed in the IFU.

Due to the reduced specificity of the product, there is a possibility of false positive results. False elevated or false positive anti-GBM results may lead the doctor to assume that the patient has anti-GBM disease mistakenly. This may lead to inappropriate therapy with glucocorticosteroids, cyclophosphamide or plasma exchange. Due to immunosuppression, potential adverse events especially include serious and opportunistic infections. Furthermore, plasmapheresis itself can cause side effects related to the procedure of central vascular access, as well as hypotension, thrombosis and infections.

Batch 2502555 has been distributed to hospitals and pathology laboratories since 22 September 2025.
Instructions for Customers/Users If customers have affected product they should:
· Review patient results that have been already obtained with the affected lot to identify if positive results could be affected by the describedproblem.
· In case of positive results (>20 U/ml): Confirm the positive Anti-GBM results obtained with the affected ORGENTEC kit lot number using an alternative method. If users have no access to an alternative method, they should contact their local distributor.
· Negative results (<20 U/ml) are not affected by the described problem and can be reported as usual.
· The use of the affected kit lot can be continued as described in the instruction for use (IFU) and following the afore described recommendations.

This action has been closed out on 08/04/2026
Action Commencement Date 17/11/2025
Responsible Entity Southern Cross Diagnostics Pty Ltd
Contact Information 02 9666 7776 - Southern Cross Diagnostics